Inflammatory response after implantation of a left ventricular assist device: Comparison between the axial flow MicroMed DeBakey VAD and the pulsatile novacor device

ASAIO Journal

Volumn 47, Issue 3, 2001, Pages 272-274

  Loebe, Matthias ^a   Koster, Andreas ^a   Sänger, Stefan ^a   Potapov, Evgenij V ^a   Kuppe, Hermann ^a   Noon, George P ^b   Hetzer, Roland ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMPLANTS (SURGICAL); PATIENT TREATMENT; TUMORS;

INFLAMMATORY SYSTEMS;

CARDIOLOGY;

COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; INTERLEUKIN 6; LEUKOCYTE ELASTASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ASSISTED CIRCULATION; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; HEART FAILURE; HUMAN; IMPLANTATION; INFLAMMATION; MALE;

EID: 0035013956     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-200105000-00023     Document Type: Article

References (17)

1. Complement activation in patients undergoing mechanical circulatory support
2. Monocyte tissue factor expression and ongoing complement generation in ventricular assist device patients
3. Left ventricular assist system support is associated with persistent inflammation and temporary immunosuppression
4. Blood contact with artificial surfaces during BVAD support
5. A miniature implantable axial flow ventricular assist device
6. The Novacor left ventricular assist system
7. Alterations in coagulation after implantation of a pulsatile Novacor LVAD and axial flow MicroMed DeBakey
8. Human recombinant C5a enhances lipopolysaccharide-induced synthesis of interleukin-6 by human monocytes
9. Time course of cytokine release and complement activation after implantation of a Heart Mate left ventricular assist device
10. Inhibition of Factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleikin-6 and neutrophil elastase
11. Interleukin-6 down regulates factor XII production by hepatoma cell line (HepG2)
12. C5a induces tissue factor activity on endothelial cells
13. Interleukin-6 stimulates neutrophil production of platelet activating factor
14. The coagulation and fibrinolytic response of baboons after in vivo thrombin generation: Effect of interleukin 6
15. Alterations in platelet function in patients receiving interleukin-6 as cytokine therapy
16. Interleukin-6 and interleukin-8 concentrations as predictors of outcome in ventricular assist device patients before heart transplantation
17. Complement, cytokines, and adhesion molecule expression in inflammatory response